华恒生物(688639.SH)：拟筹划H股上市

Core Viewpoint - The company is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its global development strategy, brand influence, and core competitiveness while optimizing its capital structure and broadening financing channels [1] Group 1 - The company aims to deepen its global development strategy and strengthen its industry-leading position [1] - The issuance of H-shares is part of the company's efforts to leverage international capital market resources and mechanisms [1] - The company is currently discussing specific details of the H-share listing with relevant intermediaries, and no changes to the controlling shareholder or actual controller will occur as a result of this listing [1]